Pharma major Lupin Limited (Lupin) has announced the completion of the United States Food and Drug Administration (U.S. FDA) inspection carried out at its Tarapur manufacturing (API) facility. The inspection was carried out between September 16 to September 20, 2019.
The inspection at the Tarapur facility closed with three observations. The Company is confident of addressing them satisfactorily.
Shares of LUPIN LTD. was last trading in BSE at Rs.756 as compared to the previous close of Rs. 741.35. The total number of shares traded during the day was 77387 in over 2080 trades.
The stock hit an intraday high of Rs. 758.7 and intraday low of 734.45. The net turnover during the day was Rs. 57960938.